The AF-1 activation-function of ERα may be dispensable to mediate the effect of estradiol on endothelial NO production in mice

Abstract

Two isoforms of estrogen receptor (ER) have been described: ERα and ERβ. The initial gene targeting of ERα, consisting in the introduction of a Neo cassette in exon 1 [αERKO, hereafter called ERα-Neo KO (knockout)], was reported in 1993. More recently, another mouse deficient in ERα because of the deletion of exon 2 (ERαKO, hereafter called ERα-Δ2 KO) was generated. In ovariectomized ERα-wild-type mice, estradiol (E 2 ) increases uterine weight and basal production of endothelial nitric oxide (NO). Both of these effects are abolished in ERα-Δ2 KO mice. In contrast, we show here that both of these effects of E 2 are partially (uterine weight) or totally (endothelial NO production) preserved in ERα-Neo KO. We also confirm the presence of two ERα mRNA splice variants in uterus and aorta from ERα-Neo KO mice. One of them encodes a chimeric ERα protein (ERα55), partially deleted in the A/B domain, that was detected in both uterus and aorta by Western blot analysis. The other ERα mRNA splice variant codes for an isoform deleted for the A/B domain (ERα46), which was detected in uterus of ERα-Neo KO, and wild-type mice. This protein isoform was not detected in aorta. The identification of these two N-terminal modified isoforms in uterus, and at least one of them in aorta, probably explains the persistence of the E 2 effects in ERα-Neo KO mice. Furthermore, ERα-Neo KO mice may help in the elucidation of the specific functions of full-length ERα (ERα66) and ERα46, both shown to be physiologically generated in vivo .